LLNI Funded Publications
Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability.
Author:Liberante FG
Other Authors: Lappin K, Barros EM, Vohhodina J, Grebien F, Savage KI, Mills KI,
Last Updated:25/07/2019
Source:PubMed
Original Source:PubMed
Type:Journal Article
DOI:10.1038/s41598-019-39591-7
Journal:Scientific reports
Volume:9
Issue:1
Pages:2678
Date: February 2019
